Company: SCLXW
Filing Date: 2025-12-29
Form Type: 424B3
Source: 0001193125-25-335429
Chunk: 234

Company: Scilex Holding Co
Filing Date: 2025-12-29
Form: 424B3
Chunk 234
---
 to exercise outstanding warrants to purchase an aggregate of 50,421 shares
of Common Stock in cash at an amended exercise price of $20.65 per share. The gross proceeds to us from such exercise was approximately $1.0 million.

Purchase Agreement

In July 2025, we
entered into the Tumim Purchase Agreement and the Tumim Registration Rights Agreement with Tumim. Pursuant to the Tumim Purchase Agreement, we have the right but not the obligation, to sell, from time to time, to Tumim up to $100.0 million in
aggregate gross purchase price of shares of Common Stock in our sole discretion, subject to certain conditions and limitations, during the term of 24 months. Through September 30, 2025, there were no sales of shares of Common Stock under the
Tumim Purchase Agreement.

In connection with the Tumim Purchase Agreement, we incurred an obligation to issue 150,000 shares of Common
Stock (“Commitment Shares Obligation”) to Tumim. The Commitment Shares Obligation was determined to be an equity-linked contract and met all the conditions for equity classification. We recognized an amount of $3.0 million in
expense and in accrued expenses.

During the three months ended September 30, 2025, there were no sales of shares of Common Stock
under the Tumim Purchase Agreement. On October 30, 2025, Tumim and the Company entered into a termination

155

agreement (the “Termination Agreement”), pursuant to which the Tumim Purchase Agreement and Tumim Registration Rights Agreement will terminate upon payment in full of the cash consideration due under the Termination Agreement, with such final payment due on December 15, 2025. Warrant Exercise Agreement On September 30, 2025, we entered to the Warrant Exercise Agreement with certain holders of the December 2024 RDO Common Warrants, pursuant to which, among other things, such holders exercised the December 2024 RDO Common Warrants to purchase 179,236 shares and deferred, for a deferral fee of $7.72 per share being exercised, their right to receive an amortization payment scheduled to be paid by us on October 1, 2025 as set forth in the amortization schedule included in the Tranche B Notes in exchange for our agreement to issue the September 2025 Warrants to purchase an aggregate of 275,000 shares of Common Stock at an